Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 374

1.

High-precision comparison of the antiproton-to-proton charge-to-mass ratio.

Ulmer S, Smorra C, Mooser A, Franke K, Nagahama H, Schneider G, Higuchi T, Van Gorp S, Blaum K, Matsuda Y, Quint W, Walz J, Yamazaki Y.

Nature. 2015 Aug 13;524(7564):196-9. doi: 10.1038/nature14861.

PMID:
26268189
2.

Clinical and analytical performance of the Onclarity HPV assay using the VALGENT framework.

Cuschieri K, Geraets DT, Moore C, Quint W, Duvall E, Arbyn M.

J Clin Microbiol. 2015 Aug 5. pii: JCM.01366-15. [Epub ahead of print]

PMID:
26246482
3.

CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies.

van Baars R, van der Marel J, Snijders PJ, Rodriquez-Manfredi A, Ter Harmsel B, van den Munckhof HA, Ordi J, Del Pino M, van de Sandt MM, Wentzensen N, Meijer CJ, Quint WG.

Int J Cancer. 2015 Jul 28. doi: 10.1002/ijc.29706. [Epub ahead of print]

PMID:
26219541
4.

Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study.

Holl K, Nowakowski AM, Powell N, McCluggage WG, Pirog EC, Collas De Souza S, Tjalma WA, Rosenlund M, Fiander A, Castro Sánchez M, Damaskou V, Joura EA, Kirschner B, Koiss R, O'Leary J, Quint W, Reich O, Torné A, Wells M, Rob L, Kolomiets L, Molijn A, Savicheva A, Shipitsyna E, Rosillon D, Jenkins D.

Int J Cancer. 2015 Jun 20. doi: 10.1002/ijc.29651. [Epub ahead of print]

PMID:
26096203
5.

The Value of Endocervical Curettage in Addition to Biopsies in Women Referred to Colposcopy.

van der Marel J, Rodriguez A, Del Pino M, van Baars R, Jenkins D, van de Sandt MM, Torné A, Ordi J, Ter Harmsel B, Verheijen RH, Schiffman M, Gage JC, Quint WG, Wentzensen N.

J Low Genit Tract Dis. 2015 Jun 16. [Epub ahead of print]

PMID:
26083332
6.

Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM.

Griffin H, Soneji Y, Van Baars R, Arora R, Jenkins D, van de Sandt M, Wu Z, Quint W, Jach R, Okon K, Huras H, Singer A, Doorbar J.

Mod Pathol. 2015 Jul;28(7):977-93. doi: 10.1038/modpathol.2015.52. Epub 2015 May 8.

PMID:
25953390
7.

Conservative Treatment Seems the Best Choice in Adenocarcinoma In Situ of the Cervix Uteri.

Baalbergen A, Molijn AC, Quint WG, Smedts F, Helmerhorst TJ.

J Low Genit Tract Dis. 2015 Jul;19(3):239-43. doi: 10.1097/LGT.0000000000000114.

PMID:
25943864
8.

Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica.

Gonzalez P, Hildesheim A, Herrero R, Katki H, Wacholder S, Porras C, Safaeian M, Jimenez S, Darragh TM, Cortes B, Befano B, Schiffman M, Carvajal L, Palefsky J, Schiller J, Ocampo R, Schussler J, Lowy D, Guillen D, Stoler MH, Quint W, Morales J, Avila C, Rodriguez AC, Kreimer AR; Costa Rica HPV Vaccine Trial (CVT) Group.

Vaccine. 2015 Apr 27;33(18):2141-51. doi: 10.1016/j.vaccine.2015.03.015. Epub 2015 Mar 18.

PMID:
25796338
9.

Disagreement in high-grade/low-grade intraepithelial neoplasia and high-risk/low-risk HPV infection: clinical implications for anal cancer precursor lesions in HIV-positive and HIV-negative MSM.

Pimenoff VN, Félez-Sánchez M, Tous S, Clavero O, Godínez JM, Klaustermeier J, Saunier M, Molijn A, Alemany L, Quint W, Bosch FX, de Sanjosé S, McCloskey J, Bravo IG.

Clin Microbiol Infect. 2015 Jun;21(6):605.e11-9. doi: 10.1016/j.cmi.2015.02.009. Epub 2015 Feb 17.

PMID:
25700891
10.

The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra.

Geraets DT, Struijk L, Kleter B, Molijn A, van Doorn LJ, Quint WG, Colau B.

J Virol Methods. 2015 Apr;215-216:22-9. doi: 10.1016/j.jviromet.2015.01.001. Epub 2015 Feb 16.

PMID:
25698462
11.

Cervicovaginal HPV infection in female renal transplant recipients: an observational, self-sampling based, cohort study.

Meeuwis KA, Hilbrands LB, IntHout J, Slangen BF, Hendriks IM, Hinten F, Christiaans MH, Quint WG, van de Kerkhof PC, Massuger LF, Hoitsma AJ, van Rossum MM, Melchers WJ, de Hullu JA.

Am J Transplant. 2015 Mar;15(3):723-33. doi: 10.1111/ajt.13053. Epub 2015 Feb 12.

PMID:
25675976
12.

HPV genotyping among women treated for high-grade cervical intraepithelial neoplasia with no lesion in the conization specimen.

Rodríguez-Manfredi Á, van Baars R, Quint WG, Sanchez MJ, Torné A, Ordi J, Del Pino M.

Int J Gynaecol Obstet. 2015 May;129(2):109-13. doi: 10.1016/j.ijgo.2014.11.009. Epub 2015 Jan 16.

PMID:
25638710
13.

Longitudinal assessment of DNA methylation changes during HPVE6E7-induced immortalization of primary keratinocytes.

Schütze DM, Kooter JM, Wilting SM, Meijer CJ, Quint W, Snijders PJ, Steenbergen RD.

Epigenetics. 2015;10(1):73-81. doi: 10.4161/15592294.2014.990787. Epub 2015 Jan 23.

PMID:
25580631
14.

Post hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNA.

Struyf F, Colau B, Wheeler CM, Naud P, Garland S, Quint W, Chow SN, Salmerón J, Lehtinen M, Del Rosario-Raymundo MR, Paavonen J, Teixeira JC, Germar MJ, Peters K, Skinner SR, Limson G, Castellsagué X, Poppe WA, Ramjattan B, Klein TD, Schwarz TF, Chatterjee A, Tjalma WA, Diaz-Mitoma F, Lewis DJ, Harper DM, Molijn A, van Doorn LJ, David MP, Dubin G; HPV PATRICIA Study Group.

Clin Vaccine Immunol. 2015 Feb;22(2):235-44. doi: 10.1128/CVI.00457-14. Epub 2014 Dec 24.

15.

Human papillomavirus prevalence and type distribution among women attending routine gynecological examinations in Saudi Arabia.

AlObaid A, Al-Badawi IA, Al-Kadri H, Gopala K, Kandeil W, Quint W, Al-Aker M, DeAntonio R.

BMC Infect Dis. 2014 Dec 14;14:643. doi: 10.1186/s12879-014-0643-8.

16.

Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing.

Porras C, Hildesheim A, González P, Schiffman M, Rodríguez AC, Wacholder S, Jiménez S, Quint W, Guillen D, Kreimer AR, Herrero R; CVT Vaccine Group.

J Natl Cancer Inst. 2014 Dec 5;107(1):400. doi: 10.1093/jnci/dju400. Print 2015 Jan.

PMID:
25479804
17.

TEMPORARY REMOVAL: The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra.

Geraets DT, Struijk L, Kleter B, Molijn A, van Doorn L, Quint WG, Colau B.

J Virol Methods. 2014 Dec 2;213C:1. doi: 10.1016/j.jviromet.2014.11.008. [Epub ahead of print]

PMID:
25476446
18.

An epidemiological study assessing the prevalence of human papillomavirus types in women in the Kingdom of Bahrain.

Moosa K, Alsayyad AS, Quint W, Gopala K, DeAntonio R.

BMC Cancer. 2014 Dec 3;14:905. doi: 10.1186/1471-2407-14-905.

19.

Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical intraepithelial neoplasia and cervical infection in young Japanese women.

Konno R, Yoshikawa H, Okutani M, Quint W, V Suryakiran P, Lin L, Struyf F.

Hum Vaccin Immunother. 2014;10(7):1781-94. doi: 10.4161/hv.28712.

20.

Attributing oncogenic human papillomavirus genotypes to high-grade cervical neoplasia: which type causes the lesion?

van der Marel J, Berkhof J, Ordi J, Torné A, Del Pino M, van Baars R, Schiffman M, Wentzensen N, Jenkins D, Quint WG.

Am J Surg Pathol. 2015 Apr;39(4):496-504. doi: 10.1097/PAS.0000000000000342.

PMID:
25353286
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk